Cancer Cells Are Protected by Abnormal Collagen Buildup
A new study led by NYU Langone researchers reveals how pancreatic tumors aid formation of dense tissue that can be a barrier to therapy.
Cancer Center Director Discusses COVID-19
Dr. Benjamin G. Neel, director of NYU Langone’s Perlmutter Cancer Center, discusses caring for people with cancer during the COVID-19 pandemic.
Cancer Center Director Discusses COVID-19 Vaccines & Cancer
Dr. Benjamin G. Neel, director of NYU Langone’s Perlmutter Cancer Center, discusses why some people with cancer might need a COVID-19 booster.
Cancer Center Faculty Are Among Highly Cited Researchers
Seven faculty members of NYU Langone’s Perlmutter Cancer Center are among Clarivate Analytics’ Highly Cited Researchers 2022 list.
Cancer Centers Call for Resumption of Screenings & Treatment
NYU Langone’s Perlmutter Cancer Center is among 76 major U.S. cancer centers and organizations urging people to resume screenings and treatment.
Cancer Centers Take Steps to Reduce COVID-19 Risks
Dr. Abraham Chachoua at NYU Langone’s Perlmutter Cancer Center discusses measures to reduce the risk of COVID-19 for people with cancer. Learn more
Cancer Diagnosis & Treatment During COVID-19
At NYU Langone’s Perlmutter Cancer Center, experts discuss cancer screenings, diagnosis, and treatment during the COVID-19 pandemic.
Cancer Doctors Have More to Learn About LGBTQ+ Health Issues
NYU Langone’s Dr. Gwendolyn P. Quinn talks to CBS News about a new study showing oncologists need more education about treating LGBTQ+ patients.
Cancer Drug Slows Heart Inflammation
Dr. Chiara Giannarelli and other experts at NYU Langone found an experimental drug may counter atherosclerosis by slowing heart inflammation.
Cancer Experts Discuss Immunotherapy’s Promises, Limitations
Immunotherapy is advancing cancer care, but there are treatment limitations. NYU Langone experts are working to strike a balance.